8.39
price down icon1.41%   -0.12
after-market  After Hours:  8.35  -0.04   -0.48%
loading
GoodRx Holdings Inc stock is currently priced at $8.39, with a 24-hour trading volume of 740.85K. It has seen a -1.41% decreased in the last 24 hours and a +12.17% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $8.57 pivot point. If it approaches the $8.38 support level, significant changes may occur.
Previous Close:
$8.51
Open:
$8.41
24h Volume:
740.85K
Market Cap:
$3.15B
Revenue:
$750.27M
Net Income/Loss:
$-8.87M
P/E Ratio:
332.94
EPS:
0.0252
Net Cash Flow:
$82.53M
1W Performance:
-5.84%
1M Performance:
+12.17%
6M Performance:
+32.54%
1Y Performance:
+46.68%
1D Range:
Value
$8.30
$8.59
52W Range:
Value
$4.135
$9.37

GoodRx Holdings Inc Stock (GDRX) Company Profile

Name
Name
GoodRx Holdings Inc
Name
Phone
855 268 2822
Name
Address
233 Wilshire Boulevard, Suite 990, Santa Monica
Name
Employee
338
Name
Twitter
Name
Next Earnings Date
2024-06-13
Name
Latest SEC Filings
Name
GDRX's Discussions on Twitter

GoodRx Holdings Inc Stock (GDRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-02-24 Downgrade BofA Securities Buy → Underperform
Aug-10-23 Upgrade DA Davidson Neutral → Buy
Jul-31-23 Upgrade TD Cowen Market Perform → Outperform
Dec-01-22 Initiated Citigroup Buy
Nov-04-22 Upgrade JP Morgan Underweight → Neutral
Sep-16-22 Initiated KeyBanc Capital Markets Sector Weight
Sep-07-22 Initiated Truist Hold
Aug-12-22 Initiated DA Davidson Neutral
Jun-10-22 Downgrade Goldman Buy → Neutral
Jun-06-22 Resumed BofA Securities Buy
Jun-01-22 Downgrade Robert W. Baird Outperform → Neutral
May-10-22 Downgrade Evercore ISI Outperform → In-line
May-10-22 Downgrade RBC Capital Mkts Outperform → Sector Perform
May-10-22 Downgrade Raymond James Outperform → Mkt Perform
May-10-22 Downgrade SVB Leerink Outperform → Mkt Perform
Apr-11-22 Initiated Wells Fargo Equal Weight
Apr-07-22 Initiated Guggenheim Buy
Apr-01-22 Resumed Credit Suisse Neutral
Mar-15-22 Upgrade Robert W. Baird Neutral → Outperform
Mar-01-22 Reiterated Barclays Overweight
Mar-01-22 Reiterated BofA Securities Neutral
Mar-01-22 Downgrade Cowen Outperform → Market Perform
Mar-01-22 Downgrade Credit Suisse Outperform → Neutral
Mar-01-22 Reiterated Evercore ISI Outperform
Mar-01-22 Reiterated Goldman Buy
Mar-01-22 Reiterated JP Morgan Underweight
Mar-01-22 Reiterated RBC Capital Mkts Outperform
Mar-01-22 Reiterated SVB Leerink Outperform
Jan-07-22 Initiated Goldman Buy
Dec-21-21 Initiated Stephens Overweight
Dec-02-21 Initiated Jefferies Buy
Aug-31-21 Upgrade Barclays Equal Weight → Overweight
Aug-13-21 Upgrade Raymond James Mkt Perform → Outperform
May-28-21 Initiated Robert W. Baird Neutral
Apr-06-21 Resumed Evercore ISI Outperform
Jan-25-21 Initiated Guggenheim Buy
Nov-19-20 Upgrade RBC Capital Mkts Sector Perform → Outperform
Nov-18-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-19-20 Initiated Barclays Equal Weight
Oct-19-20 Initiated BofA Securities Neutral
Oct-19-20 Initiated Citigroup Buy
Oct-19-20 Initiated Cowen Outperform
Oct-19-20 Initiated Credit Suisse Outperform
Oct-19-20 Initiated Deutsche Bank Hold
Oct-19-20 Initiated Goldman Neutral
Oct-19-20 Initiated JP Morgan Neutral
Oct-19-20 Initiated Morgan Stanley Overweight
Oct-19-20 Initiated RBC Capital Mkts Sector Perform
Oct-19-20 Initiated SVB Leerink Outperform
Oct-19-20 Initiated UBS Buy
View All

GoodRx Holdings Inc Stock (GDRX) Financials Data

GoodRx Holdings Inc (GDRX) Revenue 2024

GDRX reported a revenue (TTM) of $750.26 million for the quarter ending December 31, 2023, a -2.12% decline year-over-year.
loading

GoodRx Holdings Inc (GDRX) Net Income 2024

GDRX net income (TTM) was -$8.87 million for the quarter ending December 31, 2023, a +72.99% increase year-over-year.
loading

GoodRx Holdings Inc (GDRX) Cash Flow 2024

GDRX recorded a free cash flow (TTM) of $82.53 million for the quarter ending December 31, 2023, a -9.87% decrease year-over-year.
loading

GoodRx Holdings Inc (GDRX) Earnings per Share 2024

GDRX earnings per share (TTM) was -$0.02 for the quarter ending December 31, 2023, a +74.42% growth year-over-year.
loading
GoodRx Holdings, Inc. is a holding company. The company, through its subsidiaries, owns and operates a prescription drug price comparison platform using data from local and mail-order pharmacies in the United States. It also provides pharmacy coupons to customers. The company offers generic and brand name pricing; alerts clients on manufacturer co-pay cards, pharmacy discounts, and state discount programs; and provides tips on slashing drug prices. It provides prices of drugs in areas of alcohol dependence, allergies, cold, Alzheimer's disease, angina, antibiotics, anticoagulant, antiviral, antiplatelet, anxiety, arrhythmia, arrhythmia, asthma, bipolar disorder, birth control, cancer, cerebral hemorrhage, cholesterol, COPD, depression, dermatology, diabetes, ear, enlarged prostate, epilepsy, eye, fertility, fibromyalgia, flu, gastrointestinal, heart failure, hypertension, hypotension, immune system, insomnia, medical supplies, men's health, mental health, migraine, myasthenia gravis, nausea, nervous system, obesity, obsessive-compulsive disorder, opioid dependence, pain relief, arthritis, panic disorder, Parkinson's disease, PMDD, restless leg syndrome, schizophrenia, seizure, sleep aids, smoking and addiction, smoking cessation, thyroid drugs, Tourette syndrome, trazodone, urology, vaccines, and women's health. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.
health_information_services WAY
$21.62
price down icon 1.73%
$26.71
price down icon 1.00%
health_information_services EVH
$21.67
price up icon 0.00%
$28.08
price down icon 5.96%
health_information_services RCM
$12.48
price down icon 0.48%
Cap:     |  Volume (24h):